Prime Medicine, Inc. (PRME) Operating cash flow 2020–2025
Prime Medicine, Inc. (PRME) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$162.6MFY2025 · since FY2020: -$5.5M → -$162.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$162.6M | -32.3% |
| FY2024 | -$122.9M | +25.7% |
| FY2023 | -$165.4M | -25.5% |
| FY2022 | -$131.8M | -286.8% |
| FY2021 | -$34.1M | -514.8% |
| FY2020 | -$5.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PRME financial trends
PRME RevenuePRME Net incomePRME Net marginPRME Gross profitPRME Gross marginPRME Operating incomePRME Operating marginPRME Free cash flowPRME Capital expendituresPRME Return on equityPRME Stock buybacksPRME Dividends paidPRME Total assetsPRME Total liabilitiesPRME Shareholders’ equityPRME overview →